BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Increase in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 101,894 shares, a growth of 119.6% from the May 14th total of 46,393 shares. Based on an average trading volume of 3,318 shares, the short-interest ratio is currently 30.7 days. Currently, 0.1% of the company’s shares are sold short.

BioNxt Solutions Price Performance

Shares of BNXTF stock opened at $0.25 on Friday. The business’s 50 day simple moving average is $0.33 and its 200 day simple moving average is $0.40. BioNxt Solutions has a one year low of $0.14 and a one year high of $0.80. The stock has a market capitalization of $31.09 million, a PE ratio of -5.08 and a beta of 0.64.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its quarterly earnings results on Friday, May 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.